Abstract
This research focus on Taiwan ’s pharmaceutical industry’s evolution and future development trend, explore the traditional management model in detail, then summarizes the research results to propose an innovative operational model and recommendation for Taiwan’s pharmaceutical industry, with the hope that pharmaceutical companies are able to identify it’s core competencies and positioning, formulate appropriate management directions, and enhance their competitiveness in terms of R&D, manufacturing and technology, finally create corporate value via expanding internationally to achieve lean management and economies of scale. Recently, The Executive Yuan is actively promoting “Diamond Action Plan for Biotechnology” under Government strategic guidance and active investment, with the goal to break the barrier between academia and private sector by integrating all available resources. With the help from specialists in biotechnology venture capital to guide private sector by listing biotechnology as the most effective investment subject, uplifting Taiwan pharmaceutical industry as the next “100 Billion Dollar Industry” and a flourishing industry. However, in light of the fast changing structure and environment of the global pharmaceutical industry, through this paper, the author wish to remind Taiwan’s pharmaceutical companies the importance of innovation and excellence throughout the corporate development and product design process, carefully manage core competencies such as intellectual property protection, finding the “right” professional managers to lead the company in the “innovative” direction by deploying innovative management strategies to create core competencies and develop internal and external competitive advantages to achieve organization goals. Therefore, this paper also emphasizes “people” as one of the key foundations for success of the corporation.